Director/PDMR Shareholding
Bioventix PLC announced that its Chief Financial Officer, Bruce Hiscock, purchased 119 ordinary shares at an average price of 2,009 pence per share on October 27, 2025. Following this transaction, Hiscock's total beneficial interest is 1,324 ordinary shares, representing approximately 0.03% of the company's issued share capital. The purchase was executed on the London Stock Exchange, AIM Market. The ordinary shares have a nominal value of 5 pence each and are identified by the code GB00B4QVDF07.
Select text to share a quote on X · sign in to keep highlights & notes in your BVXP notes
Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, announces that the Company was notified that earlier today Bruce Hiscock, Chief Financial Officer of the Company, purchased a total of 119 ordinary shares of 5 pence each in the Company ("Ordinary Shares"), at an average price of 2,009 pence per Ordinary Share (the "Purchase").
Following the Purchase, Bruce Hiscock has a beneficial interest in 1,324 Ordinary Shares, representing approximately 0.03 per cent. of the issued share capital of the Company.
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Bruce Hiscock |
| 2. | Reason for the Notification | |
| a) | Position/status | Chief Financial Officer |
| b) | Initial notification/Amendment | Initial notification |
| a) | Name | Bioventix Plc |
| b) | LEI | 213800225MHX7LZQY108 |
| a) | Description of the Financial instrument, type of instrument | Ordinary Shares of 5 pence each |
| Identification code | GB00B4QVDF07 | |
| b) | Nature of the transaction | Purchase of Ordinary Shares |
| c) | Price(s) and volume(s) | 119 Ordinary Shares 2,009 pence |
| d) | Aggregated information: · Aggregated volume · Price | Single transaction as in 4c) above |
| e) | Date of the transaction | 27 October 2025 |
| f) | Place of the transaction | London Stock Exchange, AIM Market (XLON) |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.